Leading Advisory Firms Endorse Lynx1's Independent Nominees for Effective Board Change Lynx1's independent nominees receive strong backing from top advisory firms as shareholders urged to support potential board changes for Neuphoria Therapeutics.

Leading Advisory Firms Endorse Lynx1's Independent Nominees for Effective Board Change #United_States #Dorado #Neuphoria #Lynx1 #Stephen_Doberstein